Maternal-infant ABO blood group incongruence was associated with reduced risk for severe infection among second-born infants.

PBGENE-HBV is designed to potentially cure chronic hepatitis B by eliminating the root cause of the virus. The Food and Drug Administration (FDA) has granted Fast Track designation to PBGENE-HBV, an ...

Liver disease was associated with reduced protection against influenza-associated hospitalization following influenza vaccination.